Neurometrix Focuses on Diabetes-Related Nerve Damage

President and CEO, Dr. Shai Gozani is interviewed by OneMedRadio where he discusses the Sensus Pain Therapy device.

Read more »

NeuroMetrix Files 510(k) for SENSUS(TM) Pain Therapy Device

NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes has filed a 510(k), with the FDA for its SENSUS Pain Therapy device.

Read more »